Would you consider chemoradiation to the primary in a patient with resectable pancreatic cancer s/p neoadjuvant chemotherapy found to have single liver metastasis on re-staging?
If so, what dose and fractionation?
Answer from: Radiation Oncologist at Academic Institution
Typically it is been hard for me to reach a consensus to give radiation for oligometastatic pancreatic cancer in these situations. We have seen some 1-2 patients per year with pancreatic cancer with primary controlled die from liver failure from the liver metastases in my career. So I think that aft...